Jazz Pharmaceuticals Revenue 2007-2018 | JAZZ

Jazz Pharmaceuticals annual/quarterly revenue history and growth rate from 2007 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Jazz Pharmaceuticals revenue for the quarter ending December 31, 2018 was $0.476B, a 9.18% increase year-over-year.
  • Jazz Pharmaceuticals revenue for the twelve months ending December 31, 2018 was $1.891B, a 16.82% increase year-over-year.
  • Jazz Pharmaceuticals annual revenue for 2018 was $1.891B, a 16.82% increase from 2017.
  • Jazz Pharmaceuticals annual revenue for 2017 was $1.619B, a 8.79% increase from 2016.
  • Jazz Pharmaceuticals annual revenue for 2016 was $1.488B, a 12.32% increase from 2015.
Jazz Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $1,891
2017 $1,619
2016 $1,488
2015 $1,325
2014 $1,173
2013 $872
2012 $586
2011 $272
2010 $174
2009 $128
2008 $68
2007 $65
2006 $45
2005 $21
Jazz Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q4 2018 $476
Q3 2018 $469
Q2 2018 $500
Q1 2018 $445
Q4 2017 $436
Q3 2017 $412
Q2 2017 $394
Q1 2017 $376
Q4 2016 $397
Q3 2016 $374
Q2 2016 $381
Q1 2016 $336
Q4 2015 $341
Q3 2015 $341
Q2 2015 $334
Q1 2015 $309
Q4 2014 $328
Q3 2014 $307
Q2 2014 $291
Q1 2014 $247
Q4 2013 $236
Q3 2013 $232
Q2 2013 $208
Q1 2013 $196
Q4 2012 $184
Q3 2012 $176
Q2 2012 $124
Q1 2012 $103
Q4 2011 $84
Q3 2011 $73
Q2 2011 $65
Q1 2011 $51
Q4 2010 $53
Q3 2010 $45
Q2 2010 $40
Q1 2010 $35
Q4 2009 $38
Q3 2009 $31
Q2 2009 $37
Q1 2009 $22
Q4 2008 $20
Q3 2008 $18
Q2 2008 $16
Q1 2008 $15
Q4 2007 $15
Q3 2007 $21
Q2 2007 $14
Q1 2007 $14
Q4 2006 $0
Q3 2006 $11
Q2 2006 $11
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.384B $1.891B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $48.449B 32.20
Takeda Pharmaceutical (TAK) Japan $28.732B 10.63
Grifols (GRFS) Spain $13.029B 15.92
Ionis Pharmaceuticals (IONS) United States $10.149B 31.47
Sage Therapeutics (SAGE) United States $7.745B 0.00
Neurocrine Biosciences (NBIX) United States $7.222B 465.47
Catalent (CTLT) United States $6.473B 27.10
Nektar Therapeutics (NKTR) United States $5.420B 8.65
Tilray (TLRY) United States $4.965B 0.00
United Therapeutics (UTHR) United States $4.525B 7.70
Taro Pharmaceutical Industries (TARO) Israel $4.215B 13.57
FibroGen (FGEN) United States $4.055B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.722B 0.00
Portola Pharmaceuticals (PTLA) United States $2.432B 0.00
PTC Therapeutics (PTCT) United States $2.163B 0.00
USANA Health Sciences (USNA) United States $1.904B 15.97
Ironwood Pharmaceuticals (IRWD) United States $1.846B 0.00
Heron Therapeutics (HRTX) United States $1.840B 0.00
Xencor (XNCR) United States $1.792B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.784B 0.00
Aerie Pharmaceuticals (AERI) United States $1.783B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.696B 21.12
Endo (ENDP) Ireland $1.674B 2.58
Pacira Pharmaceuticals (PCRX) United States $1.665B 144.00
Madrigal Pharmaceuticals (MDGL) United States $1.637B 0.00
Zogenix (ZGNX) United States $1.614B 0.00
Corcept Therapeutics (CORT) United States $1.407B 20.43
Tricida (TCDA) United States $1.393B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.303B 0.00
Esperion Therapeutics (ESPR) United States $1.128B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.057B 0.00
TherapeuticsMD (TXMD) United States $0.989B 0.00
Radius Health (RDUS) United States $0.973B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.881B 0.00
CannTrust Holdings (CTST) Canada $0.799B 0.00
Akebia Therapeutics (AKBA) United States $0.752B 0.00
ChemoCentryx (CCXI) United States $0.733B 0.00
ArQule (ARQL) United States $0.693B 0.00
Odonate Therapeutics (ODT) United States $0.618B 0.00
Dermira (DERM) United States $0.593B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.582B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.571B 0.00
Forty Seven (FTSV) United States $0.561B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.554B 0.00
GlycoMimetics (GLYC) United States $0.550B 0.00
Collegium Pharmaceutical (COLL) United States $0.483B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.469B 24.21
Corbus Pharmaceuticals Holdings (CRBP) United States $0.461B 0.00
Siga Technologies (SIGA) United States $0.429B 0.00
Translate Bio (TBIO) United States $0.426B 0.00
Flexion Therapeutics (FLXN) United States $0.416B 0.00
KalVista Pharmaceuticals (KALV) United States $0.414B 0.00
OptiNose (OPTN) United States $0.410B 0.00
Aptorum Group (APM) China $0.399B 0.00
TCR2 THERAPTCS (TCRR) United States $0.388B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.385B 0.00
Mast Therapeutics (SVRA) United States $0.370B 0.00
ImmunoGen (IMGN) United States $0.363B 0.00
CASI Pharmaceuticals (CASI) United States $0.316B 0.00
Karyopharm Therapeutics (KPTI) United States $0.296B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.291B 0.00
Minerva Neurosciences (NERV) United States $0.283B 0.00
Lannett Co Inc (LCI) United States $0.282B 2.62
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.277B 10.26
Harpoon Therapy (HARP) United States $0.273B 0.00
Aclaris Therapeutics (ACRS) United States $0.264B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.257B 0.00
Xeris Pharmaceuticals (XERS) United States $0.249B 0.00
Calithera Biosciences (CALA) United States $0.247B 0.00
Dova Pharmaceuticals (DOVA) United States $0.237B 0.00
Molecular Templates (MTEM) United States $0.236B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.234B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.234B 0.00
Concert Pharmaceuticals (CNCE) United States $0.225B 0.00
Aldeyra Therapeutics (ALDX) United States $0.223B 0.00
MEI Pharma (MEIP) United States $0.221B 0.00
Rafael Holdings (RFL) United States $0.220B 0.00
Galectin Therapeutics (GALT) United States $0.218B 0.00
Affimed (AFMD) Germany $0.210B 0.00
Ardelyx (ARDX) United States $0.207B 0.00
Opexa Therapeutics (ACER) United States $0.201B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.197B 0.00
Jounce Therapeutics (JNCE) United States $0.190B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
Majesco Entertainment (PTE) United States $0.186B 0.00
Recro Pharma (REPH) United States $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.179B 185.60
AgeX Therapeutics (AGE) United States $0.177B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.177B 0.00
ElectroCore (ECOR) United States $0.173B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.173B 0.00
Redhill Biopharma (RDHL) Israel $0.172B 0.00
Ocular Therapeutix (OCUL) United States $0.170B 0.00
Aratana Therapeutics (PETX) United States $0.167B 0.00
Neon Therapeutics (NTGN) United States $0.166B 0.00
IMV INC (IMV) Canada $0.161B 0.00
Tyme Technologies (TYME) United States $0.154B 0.00
Aquestive Therapeutics (AQST) United States $0.147B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.143B 0.00
MediWound (MDWD) Israel $0.142B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.134B 0.00
ProNAi Therapeutics (SRRA) Canada $0.118B 0.00
Iterum Therapeutics (ITRM) Ireland $0.113B 0.00
China SXT Pharmaceuticals (SXTC) China $0.113B 0.00
Neos Therapeutics (NEOS) United States $0.111B 0.00
Cardiome Pharma (CORV) Canada $0.105B 0.00
Champions Oncology (CSBR) United States $0.098B 0.00
Natural Alternatives (NAII) United States $0.097B 9.46
Adamis Pharmaceuticals (ADMP) United States $0.093B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.092B 0.00
DURECT (DRRX) United States $0.092B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.090B 0.00
Nivalis Therapeutics (ALPN) United States $0.090B 0.00
Adherex Technologies (FENC) United States $0.090B 0.00
Zafgen (ZFGN) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.089B 0.00
Infinity Pharmaceuticals (INFI) United States $0.088B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Avenue Therapeutics (ATXI) United States $0.078B 0.00
Genocea Biosciences (GNCA) United States $0.076B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.066B 0.00
Capnia (SLNO) United States $0.064B 0.00
India Globalization Capital (IGC) United States $0.059B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.058B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
Melinta Therapeutics (MLNT) United States $0.054B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
Bio-Path Holdings (BPTH) United States $0.047B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.044B 0.00
KemPharm (KMPH) United States $0.043B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.042B 0.00
BioLineRx (BLRX) Israel $0.039B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.039B 0.00
ContraFect (CFRX) United States $0.038B 0.00
Heat Biologics (HTBX) United States $0.037B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
Shineco (TYHT) China $0.030B 5.08
HANCOCK JAFFE (HJLI) United States $0.029B 0.00
IsoRay (ISR) United States $0.028B 0.00
Achieve Life Sciences (ACHV) United States $0.028B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.027B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 3.38
PharmAthene (ALT) United States $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
NOVAN INC (NOVN) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Xenetic Biosciences (XBIO) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.87
PRECISION THERAPEUTICS INC (AIPT) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
Can-Fite Biopharma (CANF) Israel $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
Achaogen (AKAO) United States $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00